Edwards Lifesciences (EW) Stock Price, Quote, News & History | Benzinga

Edwards Lifesciences Corp (EW) Stock Price, Quote, News & History

EWNYSE

Trade with Public

Trade with Public

$89.75

-0.03-0.03%

Last update: Sep 4, 1:24 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$88.67

Close

-

Volume / Avg.

1.28M / 4.29M

Day Range

$88.40 - $90.07

52 Wk Range

72.30 - 96.29

Market Cap

$51.73B

P/E Ratio

53.44

Dividend Yield

-

Exchange

NYSE

RSI

49

Short Interest

2.02%

Days to Cover

3.14

Recent Edwards Lifesciences Corporation News

Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says

Edwards Lifesciences tops Q2 Wall Street estimates with $1.74B in revenue. EW stock jumps as analysts see continued upside ahead.

Vandana Singh

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Lifesciences, SAP in Focus (UPDATED)

U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's lower close.

Rishabh Mishra

American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday

US stock futures mixed, focus on companies like American Express, Deckers, Verizon, Edwards Lifesciences, and HCA Healthcare for today's trading.

Avi Kapoor

Merck To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall St analysts changed outlook on top names. KBW cut AON PT to $400, Barclay's cut T PT to $24, MS cut ROL PT to $65, GS cut SAM PT to $169, BofA raised ALLY PT to $53, Citi raised EW PT to $110, Wells Fargo raised MRK PT to $150, Jefferies raised ENVA PT.

Avi Kapoor

Darden Restaurants To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts changed outlook on top names. Wedbush raised Replimune's price target, Canaccord cut Strategy's target, Barclays upgraded Watts Water, Rosenblatt boosted Comcast, Goldman increased State Street, Evercore raised Owens Corning, Cantor Fitzgerald boosted BioCryst Pharma, BTIG raised Edwards Lifesciences.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.72B

Investing Cash Flow (TTM)

-912.10M

Financing Cash Flow (TTM)

-1.20B

Free Cash Flow (TTM)

1.43B

Capital Expenditure (TTM)

-286.70M

Net Change in Cash (TTM)

-394.80M

Analyst Trends and Forecast

5

1

Apr

3

Jun

8

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$48.20B

PE Ratio (TTM)

53.44

PE Ratio (FWD)

26.53

PEG Ratio (TTM)

1.92

PS Ratio (TTM)

8.02

PB Ratio (TTM)

4.87

Earnings Yield % (TTM)

1.87%

Earnings Yield % (FWD)

3.77%

EV / EBITDA (TTM)

29.17

Price / EBITDA (TTM)

31.60

Price / Free Cash Flow (TTM)

36.41

Book Value / Share

$18.42

Company Debt

Total Debt

$598.70M

LT Debt

$598.70M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$2.91B

Debt to Equity

0.07

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$88.67

Close

-

Volume / Avg.

1.28M / 4.29M

Day Range

$88.40 - $90.07

52 Wk Range

72.30 - 96.29

Market Cap

$51.73B

P/E Ratio

53.44

Dividend Yield

-

Exchange

NYSE

RSI

49

Short Interest

2.02%

Days to Cover

3.14

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, i...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Edwards Lifesciences (EW) stock?

A

You can purchase shares of Edwards Lifesciences (NYSE:EW) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Edwards Lifesciences (EW) competitors?

A

Other companies in Edwards Lifesciences’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for Edwards Lifesciences (EW) stock?

A

Edwards Lifesciences has a consensus price target of $99.82.

Q

What is the current price for Edwards Lifesciences (EW)?

A

The stock price for Edwards Lifesciences (NYSE: EW) is $89.75 last updated September 4, 2026 at 1:24 PM EDT.

Q

Does Edwards Lifesciences (EW) pay a dividend?

A

There are no upcoming dividends for Edwards Lifesciences.

Q

When is Edwards Lifesciences (NYSE:EW) reporting earnings?

A

Edwards Lifesciences does not have any upcoming earnings scheduled.

Q

Is Edwards Lifesciences (EW) going to split?

A

There is no upcoming split for Edwards Lifesciences.

Q

What sector and industry does Edwards Lifesciences (EW) operate in?

A

Edwards Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.